May 13 (Reuters)-
Kringle Pharma, Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Mar 31, 2022 Mar 31, 2021 Sep 30, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 27 mln 117 mln 355 mln
(-76.8 pct) (+22.6 pct)
Operating loss 310 mln loss 169 mln loss 1.36
Recurring loss 318 mln loss 191 mln loss 1.30
Net loss 319 mln loss 192 mln loss 1.30
EPS loss 70.24 yen loss 48.33 yen loss 299.22 yen
Ann Div NIL NIL
-Q2 div NIL
-Q4 div NIL NIL
NOTE - Kringle Pharma, Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4884.T